Nutritional treatment with the ketogenic diet in children with refractory epilepsy: a narrative review

Abstract

The two mainstays of therapy for refractory epilepsy are medication and surgery. Child behavioral and cognitive aspects of epilepsy can be improved by using a specialized dietary regimen such as the ketogenic diet (KD). The purpose of this review is to expand our understanding of KD as a nutritional therapy for children with refractory epilepsy and to provide insight into the physiological aspects of its efficacy as an alternative to anti-seizure medication. Either directly or indirectly, ketones, glucose restriction, and polyunsaturated fatty acids regulate epileptic seizures. For KD to be effective, all three of these components must be present, even though the exact mechanism is unknown. Increasing gamma-aminobutyric acid, mitochondrial biogenesis, and oxidative phosphorylation levels can also serve as a means of promoting stable synaptic function while also decreasing neural activity and excitability. Most side effects of KD are caused by mild metabolic abnormalities such as acidosis, hyperuricemia, hypercholesterolemia, hypocalcemia, and hypomagnesemia. Since medium-chain triglycerides (MCTs) produce more ketones per calorie than long-chain triglycerides, individuals who consume MCTs can consume more carbohydrates and protein. This review demonstrated that KD therapy led to positive outcomes for patients with refractory epilepsy. Further study is needed to evaluate whether less restrictive and easier-to-follow diets, such as the modified Atkins diet and MCT diets, have a similar effect on seizure treatment as the standard KD.

Keywords

Ketogenic diet / refractory epilepsy / ketone bodies / medium-chain triglycerides / modified Atkins diet

References

[1] Ułamek-Kozioł M,Czuczwar SJ,Januszewski S,Pluta R.Ketogenic diet and epilepsy.Nutrients.2019;11:2510.

[2] Dingledine R,Varvel NH,Dudek FE.When and how do seizures kill neurons, and is cell death relevant to epileptogenesis?.Adv Exp Med Biol.2014;813:109-22.

[3] French JA.Refractory epilepsy: clinical overview.Epilepsia.2007;48:3-7.

[4] Ferrando C,Aldecoa C,Unzueta C,Belda FJ,Librero J,Tusman G,et al.iPROVE-O2 NetworkEffects of oxygen on post-surgical infections during an individualised perioperative open-lung ventilatory strategy: a randomised controlled trial.Br J Anaesth.2020;124:110-20.

[5] Kossoff EH,Zupec-Kania BA,Auvin S,Ballaban-Gil KR,Christina Bergqvist AG,Blackford R,et al.Charlie FoundationMatthew’s FriendsPractice Committee of the Child Neurology SocietyOptimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of the International Ketogenic Diet Study Group.Epilepsia Open.2018;3:175-92.

[6] Cross JH.Dietary therapies – an old idea with a new lease of life.Seizure.2010;19:671-4.

[7] Huttenlocher PR,Wilbourn AJ,Signore JM.Medium-chain triglycerides as a therapy for intractable childhood epilepsy.Neurology.1971;21:1097-103.

[8] Augustin K,Khabbush A,Williams S,Eaton S,Orford M,Cross JH,et al.Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders.Lancet Neurol.2018;17:84-93.

[9] Kossoff EH,Krauss GL,McGrogan JR,Freeman JM.Efficacy of the Atkins diet as therapy for intractable epilepsy.Neurology.2003;61:1789-91.

[10] Kossoff EH,McGrogan JR,Bluml RM,Pillas DJ,Rubenstein JE,Vining EP.A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy.Epilepsia.2006;47:421-4.

[11] Kang HC,Lee HS,You SJ,Kang du C,Ko TS,Kim HD.Use of a modified Atkins diet in intractable childhood epilepsy.Epilepsia.2007;48:182-6.

[12] Kossoff EH,Dorward JL,Molinero MR,Holden KR.The modified Atkins diet: a potential treatment for developing countries.Epilepsia.2008;49:1646-7.

[13] Pfeifer HH,Lyczkowski DA,Thiele EA.Low glycemic index treatment: implementation and new insights into efficacy.Epilepsia.2008;49:42-5.

[14] Kossoff EH,Zupec-Kania BA,Amark PE,Ballaban-Gil KR,Christina Bergqvist AG,Blackford R,et al.The Charlie Foundation, and the Practice Committee of the Child Neurology SocietyOptimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group.Epilepsia.2009;50:304-17.

[15] Bergqvist AG,Schall JI,Gallagher PR,Cnaan A,Stallings VA.Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized clinical trial of efficacy.Epilepsia.2005;46:1810-9.

[16] Cobo NH,Sankar R,Murata KK,Sewak SL,Kezele MA,Matsumoto JH.The ketogenic diet as broad-spectrum treatment for super-refractory pediatric status epilepticus: challenges in implementation in the pediatric and neonatal intensive care units.J Child Neurol.2015;30:259-66.

[17] Pablos-Sánchez T,Oliveros-Leal L,Núñez-Enamorado N,Camacho-Salas A,Moreno-Villares JM,Simón-De las Heras R.The use of the ketogenic diet as treatment for refractory epilepsy in the paediatric age.Rev Neurol.2014;58:55-62. Spanish.

[18] Aneja S,Jain P.Refractory epilepsy in children.Indian J Pediatr.2014;81:1063-72.

[19] Berg AT,Shinnar S,Levy SR,Testa FM,Smith-Rapaport S,Beckerman B.Early development of intractable epilepsy in children: a prospective study.Neurology.2001;56:1445-52.Erratum in: Neurology. 2001;57:939.

[20] Wheless JW,Kossoff EH.80 - Ketogenic dietsSwaiman KF,Ashwal S,Ferriero DM,Schor NF,Finkel RS,Gropman AL,et al.Swaiman’s pediatric neurology (sixth edition)Elsevier; 2017. pp. 624–30.

[21] Crumrine PK.Antiepileptic drug selection in pediatric epilepsy.J Child Neurol.2002;17:2S2-8.

[22] Garnett WR.Antiepileptic drug treatment: outcomes and adherence.Pharmacotherapy.2000;20:191S-9S.

[23] Neal E.Dietary treatment of epilepsy: practical implementation of ketogenic therapy Wiley Online Books; 2012.

[24] Wyllie E.Surgical treatment of epilepsy in pediatric patients.Can J Neurol Sci.2000;27:106-10.

[25] Stafstrom CE.Animal models of the ketogenic diet: what have we learned, what can we learn?.Epilepsy Res.1999;37:241-59.

[26] Masino SA,Rho JM.Metabolism and epilepsy: ketogenic diets as a homeostatic link.Brain Res.2019;1703:26-30.